| RS1572151178 |
NCF2
|
Health Risk |
Pathogenic/Likely pathogenic |
Granulomatous disease, chronic |
| RS1572152420 |
CDC73
|
Health Risk |
Pathogenic/Likely pathogenic |
Parathyroid carcinoma, Parathyroid carcinoma |
| RS1572153816 |
PXDN
|
Health Risk |
Pathogenic |
Anterior segment dysgenesis 7, Anterior segment dysgenesis 7 |
| RS1572154885 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Parathyroid carcinoma |
| RS1572163072 |
WDR26
|
Health Risk |
Pathogenic |
Skraban-Deardorff syndrome, Skraban-Deardorff syndrome |
| RS1572168244 |
WDR26
|
Health Risk |
Likely pathogenic |
Skraban-Deardorff syndrome, Skraban-Deardorff syndrome |
| RS1572186477 |
WDR26
|
Health Risk |
Pathogenic |
— |
| RS1572191112 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1572204991 |
HSPG2
|
Health Risk |
Pathogenic |
Schwartz-Jampel syndrome type 1, Schwartz-Jampel syndrome type 1 |
| RS1572210748 |
MYOC
|
Health Risk |
Pathogenic |
Open-angle glaucoma, Open-angle glaucoma |
| RS1572215344 |
CDC73
|
Health Risk |
Pathogenic |
Parathyroid carcinoma, Parathyroid carcinoma |
| RS1572216329 |
SOX11
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with microcephaly and with or without ocular malformations or hypogonadotropic hypogonadism, Intellectual developmental disorder with microcephaly and with or without ocular malformations or hypogonadotropic hypogonadism |
| RS1572217107 |
SOX11
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with microcephaly and with or without ocular malformations or hypogonadotropic hypogonadism, Intellectual developmental disorder with microcephaly and with or without ocular malformations or hypogonadotropic hypogonadism |
| RS1572217314 |
MYCN
|
Health Risk |
Pathogenic |
Feingold syndrome type 1, Feingold syndrome type 1 |
| RS1572217664 |
TRAPPC12
|
Health Risk |
Likely pathogenic |
— |
| RS1572217717 |
MYCN
|
Health Risk |
Likely pathogenic |
— |
| RS1572218599 |
MTR
|
Health Risk |
Likely pathogenic |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS1572220282 |
HSPG2
|
Health Risk |
Pathogenic |
Schwartz-Jampel syndrome type 1, Schwartz-Jampel syndrome type 1 |
| RS1572220856 |
MYCN
|
Health Risk |
Likely pathogenic |
Feingold syndrome type 1, Feingold syndrome type 1 |
| RS1572221449 |
MYCN
|
Health Risk |
Pathogenic |
— |
| RS1572221505 |
MYCN
|
Health Risk |
Likely pathogenic |
— |
| RS1572226578 |
SELENON
|
Health Risk |
Pathogenic |
Eichsfeld type congenital muscular dystrophy, Eichsfeld type congenital muscular dystrophy |
| RS1572226620 |
SELENON
|
Health Risk |
Pathogenic |
Eichsfeld type congenital muscular dystrophy, Eichsfeld type congenital muscular dystrophy |
| RS1572226744 |
SELENON
|
Health Risk |
Pathogenic |
Eichsfeld type congenital muscular dystrophy, Eichsfeld type congenital muscular dystrophy |
| RS1572227260 |
WDR26
|
Health Risk |
Pathogenic |
Skraban-Deardorff syndrome, Skraban-Deardorff syndrome |
| RS1572227825 |
HSPG2
|
Health Risk |
Pathogenic |
— |
| RS1572255047 |
NPHS2
|
Health Risk |
Pathogenic |
Nephrotic syndrome, type 2 |
| RS1572255744 |
NPHS2
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, type 2 |
| RS1572262649 |
NPHS2
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, type 2 |
| RS1572262824 |
NPHS2
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, type 2 |
| RS1572263399 |
PRPF3
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinal dystrophy |
| RS1572263404 |
PRPF3
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 18, Retinitis pigmentosa 18 |
| RS1572277600 |
NPHS2
|
Health Risk |
Pathogenic |
Nephrotic syndrome, type 2 |
| RS1572278166 |
MTR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS1572282458 |
NPHS2
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, type 2 |
| RS1572304438 |
HSPG2
|
Health Risk |
Pathogenic |
Schwartz-Jampel syndrome, Schwartz-Jampel syndrome |
| RS1572309822 |
MTR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS1572319254 |
HSPG2
|
Health Risk |
Pathogenic |
— |
| RS1572324681 |
TBCE
|
Health Risk |
Pathogenic |
Hypoparathyroidism-retardation-dysmorphism syndrome, Hypoparathyroidism-retardation-dysmorphism syndrome |
| RS1572331707 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1572332164 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1572332235 |
LMNA
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1572332762 |
LMNA
|
Health Risk |
Likely pathogenic |
Primary familial dilated cardiomyopathy, Primary familial dilated cardiomyopathy |
| RS1572332952 |
LMNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Cardiovascular phenotype |
| RS1572337800 |
SELENOI
|
Health Risk |
Pathogenic |
Spastic paraplegia 81, autosomal recessive |
| RS1572343011 |
ARV1
|
Health Risk |
Likely pathogenic |
— |
| RS1572356343 |
HSPG2
|
Health Risk |
Likely pathogenic |
Schwartz-Jampel syndrome, Schwartz-Jampel syndrome |
| RS1572358674 |
LMNA
|
Health Risk |
Likely pathogenic |
Primary dilated cardiomyopathy, Primary dilated cardiomyopathy |
| RS1572358821 |
LMNA
|
Health Risk |
Likely pathogenic |
Primary dilated cardiomyopathy, Primary dilated cardiomyopathy |
| RS1572358860 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1572359505 |
LMNA
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1572359848 |
LMNA
|
Health Risk |
Pathogenic |
Primary dilated cardiomyopathy, Cardiovascular phenotype |
| RS1572359991 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1572360944 |
RPS7
|
Health Risk |
Likely pathogenic |
Diamond-Blackfan anemia 8, Diamond-Blackfan anemia 8 |
| RS1572362631 |
LMNA
|
Health Risk |
Likely pathogenic |
— |
| RS1572362885 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1572363397 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1572363509 |
LMNA
|
Health Risk |
Likely pathogenic |
LMNA-associated condition, LMNA-associated condition |
| RS1572364243 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1572366216 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1572366412 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1572366593 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1572366608 |
LMNA
|
Health Risk |
Likely pathogenic |
— |
| RS1572367812 |
LMNA
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Cardiovascular phenotype |
| RS1572370360 |
LMNA
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1A, Dilated cardiomyopathy 1A |
| RS1572385947 |
CPT2
|
Health Risk |
Pathogenic/Likely pathogenic |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyl transferase II deficiency |
| RS1572385973 |
CPT2
|
Health Risk |
Likely pathogenic |
Carnitine palmitoyltransferase II deficiency, Carnitine palmitoyltransferase II deficiency |
| RS1572389284 |
COLEC11
|
Health Risk |
Pathogenic |
3MC syndrome 2, 3MC syndrome 2 |
| RS1572391840 |
TBCE
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive Kenny-Caffey syndrome, Hypoparathyroidism-retardation-dysmorphism syndrome |
| RS1572399566 |
OTOF
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 9, Autosomal recessive nonsyndromic hearing loss 9 |
| RS1572399804 |
OTOF
|
Health Risk |
Pathogenic |
— |
| RS1572403809 |
KIDINS220
|
Health Risk |
Pathogenic |
— |
| RS1572418357 |
KCNT2
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 57 |
| RS1572423883 |
CAD
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 50 |
| RS1572426165 |
CAD
|
Health Risk |
Likely pathogenic |
— |
| RS1572428364 |
SEMA4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinal dystrophy |
| RS1572428834 |
KIDINS220
|
Health Risk |
Likely pathogenic |
— |
| RS1572502948 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS1572504096 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS1572513308 |
B3GALNT2
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS1572530443 |
XDH
|
Health Risk |
Pathogenic |
Hereditary xanthinuria type 1, Hereditary xanthinuria type 1 |
| RS1572531281 |
ZBTB18
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 22 |
| RS1572531730 |
ZBTB18
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 22 |
| RS1572531765 |
ZBTB18
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 22 |
| RS1572531822 |
ZBTB18
|
Health Risk |
Pathogenic |
— |
| RS1572531830 |
ZBTB18
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 22 |
| RS1572532005 |
ZBTB18
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 22 |
| RS1572542092 |
MPV17
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome 6 (hepatocerebral type), Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) |
| RS1572542511 |
MPV17
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome 6 (hepatocerebral type), Charcot-Marie-Tooth disease |
| RS1572543564 |
MPV17
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome 6 (hepatocerebral type), Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) |
| RS1572547466 |
KCNT2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Developmental and epileptic encephalopathy |
| RS1572555080 |
MPV17
|
Health Risk |
Likely pathogenic |
Mitochondrial DNA depletion syndrome 6 (hepatocerebral type), Mitochondrial DNA depletion syndrome 6 (hepatocerebral type) |
| RS1572607363 |
EIF2B4
|
Health Risk |
Pathogenic |
— |
| RS1572611822 |
MCFD2
|
Health Risk |
Likely pathogenic |
Factor 5 and Factor VIII, combined deficiency of |
| RS1572624159 |
SIX3
|
Health Risk |
Pathogenic |
Holoprosencephaly 2, Holoprosencephaly 2 |
| RS1572624326 |
SIX3
|
Health Risk |
Likely pathogenic |
SIX3-related disorder, SIX3-related disorder |
| RS1572627115 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Conduction disorder of the heart, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1572630269 |
KCNT2
|
Health Risk |
Pathogenic |
Seizure, Developmental and epileptic encephalopathy |
| RS1572697714 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1572698011 |
MSH6
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |